• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内节育器的非避孕作用

The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.

作者信息

Chi I C, Farr G

机构信息

Family Health International, Research Triangle Park, Durham 27709, USA.

出版信息

Adv Contracept. 1994 Dec;10(4):271-85. doi: 10.1007/BF01984125.

DOI:10.1007/BF01984125
PMID:7740994
Abstract

Clinical trials have consistently shown that the IUD that releases 20 micrograms levonorgestrel daily (LNG-IUD-20) has a contraceptive efficacy comparable to, if not surpassing, the Copper T380 and the Multiload Copper-375 IUDs. The focus of this review is the device's non-contraceptive effects--the beneficial ones, such as reduction of menorrhagia, a therapeutic effect on dysmenorrhea, and prevention of ectopic pregnancy, as well as the deleterious ones, such as amenorrhea, spotting and irregular bleeding, hormonal side-effects, and functional ovarian cysts. Also discussed are the possibility of a preventive effect on pelvic inflammatory disease, the effects of the IUD on postpartum/lactating women, fertility return after removal and other safety issues. In general, the LNG-IUD-20's non-contraceptive benefits are substantive, carry important medical and public health implications, and far outweigh the device's deleterious effects, which are either medically mild or transient in nature, and can usually be managed satisfactorily by counseling. A better understanding of these effects, both beneficial and deleterious, of this hormone-releasing IUD should lead to more effective patient counseling, which, in turn, should improve user quality of life, minimize unnecessary removals, and maximize continuation of use.

摘要

临床试验一直表明,每日释放20微克左炔诺孕酮的宫内节育器(LNG - IUD - 20)的避孕效果即便不超过铜T380和多负载铜375宫内节育器,也与之相当。本综述的重点是该装置的非避孕作用——有益作用,如减少月经过多、对痛经有治疗作用以及预防异位妊娠;还有有害作用,如闭经、点滴出血和不规则出血、激素副作用以及功能性卵巢囊肿。还讨论了对盆腔炎的预防作用可能性、宫内节育器对产后/哺乳期妇女的影响、取出后生育能力恢复情况以及其他安全问题。总体而言,LNG - IUD - 20的非避孕益处显著,具有重要的医学和公共卫生意义,且远远超过该装置的有害作用,这些有害作用在医学上要么轻微,要么是短暂的,通常通过咨询就能得到令人满意的处理。更好地了解这种释放激素的宫内节育器的这些有益和有害作用,应能带来更有效的患者咨询,进而改善使用者的生活质量,尽量减少不必要的取出,并最大限度地提高继续使用率。

相似文献

1
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.左炔诺孕酮宫内节育器的非避孕作用
Adv Contracept. 1994 Dec;10(4):271-85. doi: 10.1007/BF01984125.
2
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.左炔诺孕酮宫内节育器评估:与含铜宫内节育器相比的优缺点。
Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t.
3
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.左炔诺孕酮宫内节育器作为一种具有治疗特性的避孕方法。
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
4
Hormonal intrauterine devices.激素宫内节育器
Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158.
5
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的风险效益评估。
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
6
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.左炔诺孕酮与铜宫内节育两年:TCu 380Ag与左炔诺孕酮20微克/天装置的随机对照比较。
Contraception. 1987 Mar;35(3):245-55. doi: 10.1016/0010-7824(87)90026-6.
7
Intrauterine devices: an effective alternative to oral hormonal contraception.宫内节育器:口服激素避孕的有效替代方法。
Prescrire Int. 2009 Jun;18(101):125-30.
8
Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.长效宫内避孕:左炔诺孕酮20微克/天(LNG 20)与铜T380A宫内节育器的七年随机研究。
Contraception. 1991 Nov;44(5):473-80. doi: 10.1016/0010-7824(91)90149-a.
9
Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.月经后及流产后插入铜宫内节育器或左炔诺孕酮宫内缓释系统后月经出血模式的详细分析。
Contraception. 1996 Oct;54(4):201-8. doi: 10.1016/s0010-7824(96)00189-8.
10
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.左炔诺孕酮20微克/天(LNG 20)和铜T 380Ag宫内节育器的长期避孕效果:一项为期五年的随机研究。
Contraception. 1990 Oct;42(4):361-78. doi: 10.1016/0010-7824(90)90046-x.

引用本文的文献

1
Oral and intrauterine progestogens for atypical endometrial hyperplasia.用于非典型子宫内膜增生的口服和宫内孕激素
Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD009458. doi: 10.1002/14651858.CD009458.pub3.
2
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的风险效益评估。
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.